← Back to Clinical Trials
Recruiting NCT06845657

NCT06845657 Hip Abductor Strengthening Exercises in Knee Osteoarthritis

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06845657
Status Recruiting
Phase
Sponsor Riphah International University
Condition Knee Osteoarthritis
Study Type INTERVENTIONAL
Enrollment 40 participants
Start Date 2025-03-03
Primary Completion 2026-02-16

Eligibility & Interventions

Sex All sexes
Min Age 40 Years
Max Age 60 Years
Study Type INTERVENTIONAL
Interventions
Hip Abductor Strengthening ExercisesConventional Treatment

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 40 participants in total. It began in 2025-03-03 with a primary completion date of 2026-02-16.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The aim of this randomized controlled trial is to find the effect of hip abductor strengthening exercises on pain, range of motion, functional disability and balance in patient with knee osteoarthritis.

Eligibility Criteria

Inclusion Criteria: * • Age group 40-60 * Both genders male and female * Have had knee pain for 3 months or more * Report a minimum average overall pain severity of 4 on an 11-point numeric rating scale (NPRS) over the previous week * grade II and III on X-ray (Kellgren and Lawrence classification); * For participants with bilateral knee osteoarthritis, the more seriously affected side (as identified by the Kellgren-Lawrence grade of knee osteoarthritis and the pain intensity) was selected as the affected leg. * willing to participate in intervention program Exclusion Criteria: * • history of surgery of lower limb * Past knee fracture or malignancy * individuals with known hip OA and/or previous trauma affecting one or both hips * Intraarticular corticosteroid injection into the knee within previous 3 months. * Pregnancy

Contact & Investigator

Central Contact

KINZA ANWAR, MS-OMPT

✉ kinza.anwar@riphah.edu.pk

📞 +92-3239735427

Principal Investigator

KINZA ANWAR, MS-OMPT

PRINCIPAL INVESTIGATOR

Riphah International University

Frequently Asked Questions

Who can join the NCT06845657 clinical trial?

This trial is open to participants of all sexes, aged 40 Years or older, up to 60 Years, studying Knee Osteoarthritis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06845657 currently recruiting?

Yes, NCT06845657 is actively recruiting participants. Contact the research team at kinza.anwar@riphah.edu.pk for enrollment information.

Where is the NCT06845657 trial being conducted?

This trial is being conducted at Islamabad, Pakistan.

Who is sponsoring the NCT06845657 clinical trial?

NCT06845657 is sponsored by Riphah International University. The principal investigator is KINZA ANWAR, MS-OMPT at Riphah International University. The trial plans to enroll 40 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology